Christine Lens, CEO of KEYBIO is excited: “it was our goal to find a strategic and international partner who follows a similar entrepreneurial spirit as we do. With Tentamus we found exactly that, which enables us to grow even faster now and support our customers’ needs and wants locally and globally. Joining the worldwide laboratory network of Tentamus opens new opportunities for us and our customers. We are delighted and excited about the journey ahead.”
“KEYBIO widens the geographic footprint of the Tentamus Group, marking the first physical entry into the French Market, while expanding the scope and expertise in the pharmaceutical, cosmetic and medical device testing field. More so, the new state-of-the-art facility is currently being finalized enabling the new partnership to be facilitated with the space, equipment and facilities to cater to all current and future needs of the customers and employees alike”, Abgar Barseyten, CEO Tentamus Group. “It is an exceptional opportunity for both groups to utilize their synergies to grow the network and widen our joint presence well beyond what could be achieved independently”.
KEYBIO will reinforce Tentamus’ footprint as well as expand client reach in France. The testing laboratories provide safety testing with a strong competence in microbiology, as well as sterility analysis for medical device, pharmaceutical, cosmetic and biocidal markets. In return, KEYBIO will have access to the entire Tentamus portfolio of services and infrastructure, and benefit from the Group’s network, thereby allowing KEYBIO to further penetrate their local market, and increase their share of their clients’ testing spend.
About KEYBIO
KEYBIO is an independent, COFRAC[1] accredited, and FDA and French drug administration registered CRO, headquartered out of Aubagne (near Marseille), France with close to 50 highly dedicated professionals providing a full scope of services. KEYBIO was established back in 1992 by Christine Lens and Jean-Jérôme Lucchini is specialized in microbiology and researches in the field of antimicrobial agents. Further information and detailed testing services can be found at https://keybio.com
[1] www.COFRAC.fr
“KEYBIO widens the geographic footprint of the Tentamus Group, marking the first physical entry into the French Market, while expanding the scope and expertise in the pharmaceutical, cosmetic and medical device testing field. More so, the new state-of-the-art facility is currently being finalized enabling the new partnership to be facilitated with the space, equipment and facilities to cater to all current and future needs of the customers and employees alike”, Abgar Barseyten, CEO Tentamus Group. “It is an exceptional opportunity for both groups to utilize their synergies to grow the network and widen our joint presence well beyond what could be achieved independently”.
KEYBIO will reinforce Tentamus’ footprint as well as expand client reach in France. The testing laboratories provide safety testing with a strong competence in microbiology, as well as sterility analysis for medical device, pharmaceutical, cosmetic and biocidal markets. In return, KEYBIO will have access to the entire Tentamus portfolio of services and infrastructure, and benefit from the Group’s network, thereby allowing KEYBIO to further penetrate their local market, and increase their share of their clients’ testing spend.
About KEYBIO
KEYBIO is an independent, COFRAC[1] accredited, and FDA and French drug administration registered CRO, headquartered out of Aubagne (near Marseille), France with close to 50 highly dedicated professionals providing a full scope of services. KEYBIO was established back in 1992 by Christine Lens and Jean-Jérôme Lucchini is specialized in microbiology and researches in the field of antimicrobial agents. Further information and detailed testing services can be found at https://keybio.com
[1] www.COFRAC.fr
